Send to a Friend Font Size: Increase Decrease

SAN and REGN Related Headlines

Nov 25, 2025 01:00AM Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)

SAN and REGN Related Press Releases

Nov 25, 2025 01:00AM Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU)

SAN and REGN Related SEC Filings